- Home
- TRST vs OCS Comparison
TRST vs OCS Comparison
Compare TRST & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRST | OCS |
|---|---|---|
| Founded | 1902 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 858.9M | 732.4M |
| IPO Year | 1994 | 2022 |
Fundamental Metrics
Financial Performance| Metric | TRST | OCS |
|---|---|---|
| Price | $55.37 | $8.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $36.73 |
| AVG Volume (30 Days) | 76.9K | ★ 312.2K |
| Earning Date | 10-21-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.88% | N/A |
| EPS Growth | ★ 26.46 | N/A |
| EPS | ★ 1.89 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $365.20 |
| P/E Ratio | $29.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $36.93 | $7.11 |
| 52 Week High | $59.28 | $34.48 |
Technical Indicators
Market Signals| Indicator | TRST | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 54.89 | 38.73 |
| Support Level | $55.29 | $7.11 |
| Resistance Level | $56.13 | $13.49 |
| Average True Range (ATR) | 1.10 | 0.46 |
| MACD | 0.21 | 0.13 |
| Stochastic Oscillator | 96.45 | 52.03 |
Price Performance
Historical ComparisonAbout TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company derives revenue from the business of Banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.